256 related articles for article (PubMed ID: 18260726)
1. Validation study of a quality of life (QOL) questionnaire for use in Iran.
Safaee A; Moghim Dehkordi B
Asian Pac J Cancer Prev; 2007; 8(4):543-6. PubMed ID: 18260726
[TBL] [Abstract][Full Text] [Related]
2. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
3. Questionnaire to assess quality of life in patients with breast cancer - Validation of the Chinese version of the EORTC QLQ-BR 53.
Zhang Z; Zhang X; Wei L; Lin Y; Wu D; Xie S; Yue L; Tian J; Zhang Y; Song Q; Woo SM; Miller AR; Luo L; Zhang L
Breast; 2017 Apr; 32():87-92. PubMed ID: 28068605
[TBL] [Abstract][Full Text] [Related]
4. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
[TBL] [Abstract][Full Text] [Related]
5. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
[TBL] [Abstract][Full Text] [Related]
6. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
[TBL] [Abstract][Full Text] [Related]
7. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): validation study of the Thai version.
Silpakit C; Sirilerttrakul S; Jirajarus M; Sirisinha T; Sirachainan E; Ratanatharathorn V
Qual Life Res; 2006 Feb; 15(1):167-72. PubMed ID: 16411041
[TBL] [Abstract][Full Text] [Related]
8. Psychometric validation of the Moroccan version of the EORTC QLQ-C30 in colorectal Cancer patients: cross-sectional study and systematic literature review.
El Alami Y; Essangri H; Majbar MA; Boutayeb S; Benamr S; El Malki HO; Souadka A
BMC Cancer; 2021 Jan; 21(1):99. PubMed ID: 33499819
[TBL] [Abstract][Full Text] [Related]
9. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): translation and validation study of the Iranian version.
Montazeri A; Harirchi I; Vahdani M; Khaleghi F; Jarvandi S; Ebrahimi M; Haji-Mahmoodi M
Support Care Cancer; 1999 Nov; 7(6):400-6. PubMed ID: 10541982
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients.
Demirci S; Eser E; Ozsaran Z; Tankisi D; Aras AB; Ozaydemir G; Anacak Y
Asian Pac J Cancer Prev; 2011; 12(5):1283-7. PubMed ID: 21875283
[TBL] [Abstract][Full Text] [Related]
11. Psychometric properties and measurement equivalence of the Multidimensional Fatigue Syndrome Inventory- Short Form (MFSI-SF) amongst breast cancer and lymphoma patients in Singapore.
Chan A; Lew C; Wang XJ; Ng T; Chae JW; Yeo HL; Shwe M; Gan YX
Health Qual Life Outcomes; 2018 Jan; 16(1):20. PubMed ID: 29351803
[TBL] [Abstract][Full Text] [Related]
12. Cross-cultural verification of the EORTC QLQ-C15-PAL questionnaire in mainland China.
Zhang L; Wang N; Zhang J; Liu J; Luo Z; Sun W; Woo SM; Chen C; Zhang K; Miller AR; Guo H; Zhang X; Wang C
Palliat Med; 2016 Apr; 30(4):401-8. PubMed ID: 26121985
[TBL] [Abstract][Full Text] [Related]
13. Psychometric Validation of the Malaysian Chinese Version of the EORTC QLQ-C30 in Colorectal Cancer Patients.
Magaji BA; Moy FM; Roslani AC; Law CW; Sagap I
Asian Pac J Cancer Prev; 2015; 16(18):8107-12. PubMed ID: 26745046
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
15. [Validity and reliability of the quality of life questionnaire (EORTC QLQ C30) and its breast cancer module (EORTC QLQ BR23)].
Zawisza K; Tobiasz-Adamczyk B; Nowak W; Kulig J; Jedrys J
Ginekol Pol; 2010 Apr; 81(4):262-7. PubMed ID: 20476597
[TBL] [Abstract][Full Text] [Related]
16. Psychometric analysis of a Persian version of the European Organization for Research and Treatment of Cancer OG25 Quality of Life Questionnaire in oesophagogastric cancer patients.
Hesari AE; Lari MA; Shandiz FH
Asian Pac J Cancer Prev; 2014; 15(6):2739-45. PubMed ID: 24761894
[TBL] [Abstract][Full Text] [Related]
17. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer (EORTC) Breast-Cancer-Specific Quality of Life Questionnaire (EORTC QLQ-BR23).
Yun YH; Bae SH; Kang IO; Shin KH; Lee R; Kwon SI; Park YS; Lee ES
Support Care Cancer; 2004 Jun; 12(6):441-5. PubMed ID: 15088137
[TBL] [Abstract][Full Text] [Related]
18. Psychometric evaluation of the Persian version of the Lymphedema Life Impact Scale (LLIS, version 1) in breast cancer patients.
Haghighat S; Montazeri A; Zayeri F; Ebrahimi M; Weiss J
Health Qual Life Outcomes; 2018 Jun; 16(1):132. PubMed ID: 29954381
[TBL] [Abstract][Full Text] [Related]
19. The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ).
Alexander M; Berger W; Buchholz P; Walt J; Burk C; Lee J; Arbuckle R; Abetz L
Health Qual Life Outcomes; 2005 Oct; 3():67. PubMed ID: 16259630
[TBL] [Abstract][Full Text] [Related]
20. Psychometric properties of the Arabic version of EORTC QLQ-C15-PAL among cancer patients in Jordan.
Alawneh A; Yasin H; Khirfan G; Qayas BA; Ammar K; Rimawi D; Klepstad P
Support Care Cancer; 2016 Jun; 24(6):2455-62. PubMed ID: 26660151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
